Neonate exposure to thimerosal mercury from hepatitis B vaccines

American Journal of Perinatology

Volumn 26, Issue 7, 2009, Pages 523-527

  Dórea, José G ^a,b   Marques, Rejane C ^b   Brandão, Katiane G ^b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b UNIVERSIDADE FEDERAL DE RONDÔNIA   (Brazil)

Author keywords

Ethylmercury; Hepatitis B; Immunization; Newborns; Thimerosal

Indexed keywords

ETHYLMERCURY DERIVATIVE; EUVAX B INJECTABLE; HEBERBIOVAC HB; HEPATITIS B VACCINE; THIOMERSAL; UNCLASSIFIED DRUG; VACINA RECOMBINANTE;

ARTICLE; BIRTH; BIRTH WEIGHT; BODY MASS; BODY WEIGHT; CHILD; DELIVERY; DRUG MANUFACTURE; DRUG MEGADOSE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; METABOLISM; NEWBORN; PERINATAL PERIOD; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; TOXICOKINETICS; VACCINATION; WEIGHT REDUCTION;

BRAZIL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; PRESERVATIVES, PHARMACEUTICAL; REGISTRIES; RISK ASSESSMENT; THIMEROSAL; VACCINATION;

EID: 67749091331     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1215431     Document Type: Article

References (38)

1. Dórea JG. Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors. Am J Perinatol 2007;24:387-400
2. van't Veen AJ. Vaccines without thiomersal: why so necessary, why so long coming? Drugs 2001;61:565-572
3. Magos L, Brown AW, Sparrow S, Bailey E, Snowden RT, Skipp WR. The comparative toxicology of ethyl- and methylmercury. Arch Toxicol 1985;57:260-267
4. Harry GJ, Harris MW, Burka LT. Mercury concentrations in brain and kidney following ethylmercury, methylmercury and thimerosal administration to neonatal mice. Toxicol Lett 2004;154:183-189
5. Trasande L, Landrigan PJ, Schechter C. Public health and economic consequences of methyl mercury toxicity to the developing brain. Environ Health Perspect 2005;113:590-596
6. Cohen JT, Bellinger DC, Shaywitz BA. A quantitative analysis of prenatal methyl mercury exposure and cognitive development. Am J Prev Med 2005;29:353-365
7. Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 2006;12:203-209
8. Axelrad DA, Bellinger DC, Ryan LM, Woodruff TJ. Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect 2007;115:609-615
9. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997;19:417-428
10. Magos L. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants. J Appl Toxicol 2003;23:263-269
11. Verstraeten T, Davis RL, DeStefano F, et al; Vaccine Safety Datalink Team. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 2003;112:1039-1048
12. Heron J, Golding J; ALSPAC Study Team. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004;114:577-583
13. Thompson WW, Price C, Goodson Bet alVaccine Safety Datalink Team. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007;357:1281-1292
14. Geier DA, Geier MR. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuroendocrinol Lett 2006;27:401-413
15. Young HA, Geier DA, Geier MR. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 2008;271:110-118
16. Marques RC, Bernardi JV, Dórea JG, Bastos WR, Malm O. Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury. Int J Hyg Environ Health 2008;211:606-614
17. Gallagher C, Goodman M. Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years. Toxicol Environ Chem 2008;90:997-1008
18. Dórea JG, Marques RC. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines. Toxicol Sci 2008;103:414-415
19. Marques RC, Dórea JG, Manzatto AG, Bastos WR, Bernardi JV, Malm O. Time of perinatal immunization, thimerosal exposure and neurodevelopment at 6 months in breastfed infants. Acta Paediatr 2007;96:864-868
20. Zheng W, Dreskin SC. Thimerosal in influenza vaccine: an immediate hypersensitivity reaction. Ann Allergy Asthma Immunol 2007;99:574-575
21. Coulter DM. Prolactin: a hormonal regulator of the neonatal tissue water reservoir. Pediatr Res 1983;17:665-668
22. Minami T, Oda K, Gima N, Yamazaki H. Effects of lipopolysaccharide and chelator on mercury content in the cerebrum of thimerosal-administered mice. Environ Toxicol Pharmacol 2007;24:316-320
23. Berman RF, Pessah IN, Mouton PR, Mav D, Harry J. Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol Sci 2008;101:294-309
24. Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005;113:1015-1021
25. Hossain MA, Islam MN, Shahidullah M, Akhter H. Pattern of change of weight following birth in the early neonatal period. Mymensingh Med J 2006;15:30-32
26. Metaj M, Laroia N, Lawrence RA, Ryan RM. Comparison of breast- and formula-fed normal newborns in time to first stool and urine. J Perinatol 2003;23:624-628
27. Dollberg S, Lahav S, Mimouni FB. A comparison of intakes of breast-fed and bottle-fed infants during the first two days of life. J Am Coll Nutr 2001;20:209-211
28. Bartelink IH, Rademaker CM, Schobben AF, van den Anker JN. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006;45:1077-1097
29. Pichichero ME, Gentile A, Giglio N, et al. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics 2008;121:e208-e214
30. Stajich GV, Lopez GP, Harry SW, Sexson WR. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J Pediatr 2000;136:679-681
31. Korbas M, Blechinger SR, Krone PH, Pickering IJ, George GN. Localizing organomercury uptake and accumulation in zebrafish larvae at the tissue and cellular level. Proc Natl Acad Sci U S A 2008;105:12108-12112
32. Geier MR, Geier DA, Zahalsky AC. A review of hepatitis B vaccination. Expert Opin Drug Saf 2003;2:113-122
33. Eales SJ. Hepatitis B vaccine at birth - just another barrier to breastfeeding? Aust Midwifery 2003;16:4-5
34. McIntyre P, Wood N. Does universal hepatitis B vaccination at birth have a negative impact on breastfeeding? Aust Midwifery 2004;17:4-5
35. Mansoor OD, Salama P. Should hepatitis B vaccine be used for infants? Expert Rev Vaccines 2007;6:29-33
36. Bondy SC, Campbell A. Developmental neurotoxicology. J Neurosci Res 2005;81:605-612
37. Wigzell H. Difficulties in replacing mercury as a preservative in bacterial vaccines. Lakartidningen 1990;87:621
38. Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 200810.1212/01.wnl.0000335762.42177.07